Table 1 Clinical characteristics of the nonrecurrence group and recurrence group.
From: Radiomics analysis of contrast-enhanced T1W MRI: predicting the recurrence of acute pancreatitis
Ā | Nonrecurrence group (nā=ā102) | Recurrence group (nā=ā99) | P value |
---|---|---|---|
Age (years) | 50.02ā±ā15.66 | 47.01ā±ā14.51 | 0.159 |
Sex (male/female) | 54/48 | 71/28 | 0.006* |
Hyperlipidemia (n/%) | 26/25.50 | 65/65.70 | 0.000* |
Alcoholism (n/%) | 32/31.40 | 44/44.40 | 0.056 |
Smoking (n/%) | 29/28.40 | 48/48.50 | 0.003* |
Serum amylase | 602.85 (288.35ā1379.75) | 420.80 (288.35ā1379.75) | 0.052 |
Lipase | 945.40 (282.03ā1789.20) | 689.00 (356.60ā1340.80) | 0.611 |
Pancreatic amylase | 534.55 (201.70ā1166.10) | 411.00 (193.20ā821.00) | 0.133 |
Biliary stones (n/%) | 36/35.30 | 37/37.40 | 0.759 |
Local complications (n/%) | 73/71.60 | 48/48.50 | 0.001* |
MRSI | 5 (3ā7) | 4 (2ā6) | 0.004* |
Disease severity (n/%) | Ā | Ā | 0.018* |
Mild | 21/20.60 | 38/38.40 | Ā |
Moderate | 53/52.00 | 43/43.40 | Ā |
Severe | 28/27.50 | 18/18.20 | Ā |